These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12838969)

  • 1. EORTC-NCI-AACR--14th Symposium. Molecular targets and cancer therapeutics--part II. 19-22 November 2002, Frankfurt, Germany.
    Patterson C
    IDrugs; 2003 Jan; 6(1):27-9. PubMed ID: 12838969
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in the management of colorectal cancer.
    Van Cutsem E; Dicato M; Wils J
    Eur J Cancer; 2001 Dec; 37(18):2302-9. PubMed ID: 11720822
    [No Abstract]   [Full Text] [Related]  

  • 3. [New therapeutic targets and strategies in lung cancer].
    Sánchez De Cos Escuín J
    Arch Bronconeumol; 2002 Aug; 38(8):386-91. PubMed ID: 12199921
    [No Abstract]   [Full Text] [Related]  

  • 4. EORTC-NCI-AACR--14th Symposium. Molecular targets and cancer therapeutics--part I. 19-22 November 2002, Frankfurt, Germany.
    Patterson C
    IDrugs; 2003 Jan; 6(1):23-6. PubMed ID: 12838967
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular-targeted anticancer therapy: challenges related to study design and choice of proper endpoints.
    Gasparini G; Gion M
    Cancer J; 2000; 6(3):117-31. PubMed ID: 10882325
    [No Abstract]   [Full Text] [Related]  

  • 6. Researchers describe findings for targeted cancer therapies.
    Stephenson J
    JAMA; 2000 Jul; 284(3):293-5. PubMed ID: 10891943
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiangiogenesis: current clinical data and future perspectives.
    Drevs J; Laus C; Medinger M; Schmidt-Gersbach C; Unger C
    Onkologie; 2002 Dec; 25(6):520-7. PubMed ID: 12566896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: promises and pitfalls.
    Csaky K
    Ophthalmology; 2003 May; 110(5):879-81. PubMed ID: 12750083
    [No Abstract]   [Full Text] [Related]  

  • 9. New chemotherapeutic agents: update of major chemoradiation trials in solid tumors.
    Curran WJ
    Oncology; 2002; 63 Suppl 2():29-38. PubMed ID: 12466642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapy in non-small-cell lung cancer.
    Herbst RS
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 9):19-24. PubMed ID: 12375797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
    Jain RK
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):3-9. PubMed ID: 12516032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic approaches to the treatment of gastrointestinal malignancy.
    Rosen LS
    Curr Opin Oncol; 2002 Jul; 14(4):431-8. PubMed ID: 12130929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenesis drug promising for metastatic colorectal cancer.
    McCarthy M
    Lancet; 2003 Jun; 361(9373):1959. PubMed ID: 12801743
    [No Abstract]   [Full Text] [Related]  

  • 14. 14th EORTC-NCI-AACR symposium on "Molecular Targets and Cancer Therapeutics," November 19-22, 2002, Frankfurt, Germany.
    Evans AE
    Med Pediatr Oncol; 2003 Dec; 41(6):541-4. PubMed ID: 14595711
    [No Abstract]   [Full Text] [Related]  

  • 15. The von Hippel-Lindau protein, vascular endothelial growth factor, and kidney cancer.
    George DJ; Kaelin WG
    N Engl J Med; 2003 Jul; 349(5):419-21. PubMed ID: 12890838
    [No Abstract]   [Full Text] [Related]  

  • 16. From bench top to bedside.
    Barinaga M
    Science; 1997 Nov; 278(5340):1036-9. PubMed ID: 9381201
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of metastatic colorectal cancer with monoclonal antibody to vascular endothelial growth factor: does the metastatic site make the difference?
    Graziano F; Cascinu S
    J Clin Oncol; 2003 Sep; 21(18):3542-3; author reply 3543. PubMed ID: 12972535
    [No Abstract]   [Full Text] [Related]  

  • 18. Research retreat: Pfizer eliminates Sugen, shrinks cancer infrastructure.
    Garber K
    J Natl Cancer Inst; 2003 Jul; 95(14):1036-8. PubMed ID: 12865446
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
    Ferrara N
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer therapy with angiogenesis inhibitors.
    Ghilardi C; Bani MR; Giavazzi R
    Tumori; 2001; 87(6):S14-6. PubMed ID: 11989610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.